Interstitial pathomechanisms underlying progressive tubulointerstitial damage

Kidney and Blood Pressure Research

Volumn 22, Issue 1-2, 1999, Pages 71-80

  Strutz, Frank ^a   Müller, Gerhard A ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

End stage renal failure; Fibroblast; Fibrosis; Renal fibrogenesis; Tubular epithelial cell

Indexed keywords

EPITHELIUM CELL; FIBROBLAST; FIBROGENESIS; HISTOLOGY; INFLAMMATION; KIDNEY FAILURE; KIDNEY INTERSTITIUM; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE EPITHELIUM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; DISEASE PROGRESSION; FIBROSIS; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY TUBULES;

EID: 0345379614     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000025911     Document Type: Review

References (91)

1. US Renal Data System U: Annual Data Report, National Institute of Diabetes and Digestive and Kidney Diseases, The National Institutes of Health. Bethesda, Md. April 1998.
2. Fogo AB, Kon V: Pathophysiology of progressive renal disease; in Neilson EG, Couser WG (eds): Immunologic Renal Diseases. Philadelphia. Lippincott-Raven, 1997: pp 683-704.
3. Strutz F, Müller GA: Renal fibrogenesis and progression; in: Neilson EG, Couser WC (eds): Immunologic Renal Diseases. Philadelphia, Lipincott-Raven, 1997; pp 705-726.
4. Palmer BF: The renal tubule in the progression of chronic renal failure. J Invest Med 1997;45: 346-361.
5. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 1994;45:916-927.
6. Nath KA: The tubulointerstitium in progressive renal disease. Kidney Int 1998;54:992-994.
7. Henle J, Pfeufer C: Morbus Bright, klinische Mitteilungen. Z Rationelle Med. Zürich 1844;1.
8. Toynbee J: On the intimate structure of the human kidney and on the changes of its several component parts under Bright's disease. Med Chir Trans 1846;29:304-324.
9. Spühler O, Zollinger HU: Die chronische interstitielle Nephritis. Z Klin Med 1953;131: 1-50.
10. Hutt MSR, Pinniger JL, deWardener HE: The relationship between the clinical and the histological features of acute glomerular nephritis. Q J Med 1958;106:265-291.
11. Risdon RA, Sloper JAC, Wardener HEd: Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968;ii:363-366.
12. Striker GE, Schainuck LI, Cutler RE, Benditt EP: Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease. Hum Pathol 1970;1:615-630.
13. Schainuck LI, Striker GE, Cutler RE, Benditt EP: Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1970; 1:631-641.
14. Bohle A, Strutz F, Müller GA: On the pathogcncsis of chronic renal failure in primary glomerulopathies. Exp Nephrol 1994;2:205-210.
15. Bohle A, Wehrmann M, Bogenschütz O, et al: The long-term prognosis of the primary glomerulonephritides. Pathol Res Pract 1992; 188:908-924.
16. Roberts JA: Mechanisms of renal damage in chronic pyelonephritis (reflux nephropathy). Curr Top Pathol 1995;88:265-287.
17. Walker WG: Hypertension-related renal injury: A major contributor to end-stage renal disease. Am J Kidney Dis 1993;22:164-173.
18. Wilson PD, Falkenstein D: The pathology of human renal cystic disease. Curr Top Pathol 1995;88:1-50.
19. Ziyadeh F: The significance of tubulointerstitial changes in diabetic renal disease. Kidney Int. 1996;54(suppl):510-513.
20. Ljungquist A: The intrarenal arterial pattern in the normal and diseased human kidney. Acta Med Scand 1963;174(suppl 401):5-34.
21. Bohle A, Gise HV, Mackensen-Haen S, StarkJakob B: The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Klin Wochenschr 1981;59:1043-1051.
22. Bader R, Bader H, Grund KE, MackensenHaen S, Christ H, Bohle A: Structure and function of the kidney in diabetic glomerulosclerosis: Correlations between morphological and functional parameters. Pathol Res Pract 1980; 167:204-216.
23. Møller JC: Dimensional changes of proximal tubules and cortical capillaries in chronic obstructive renal disease. Virchows Arch [A] 1986;410:153-158.
24. Knecht A, Fine LG, Kleinman KS, et al: Fibroblasts of rabbit kidney in culture. II. Paracrine stimulation of papillary fibroblasts by PDGF. Am J Physiol 1991;261:F292-F299.
25. Wolf G, Neilson EG: Angiotensin II as a renal growth factor. J Am Soc Nephrol 1993;3: 1531-1540.
26. Ong ACM, Jowett TP, Firth JD, Burton S, Kitamura M, Fine LG: Human-tubular derived endothelin in the paracrine regulation of renal interstitial fibroblast function. Exp Nephrol 1994;2:134.
27. Savill J, Mooney A, Hughes J: Apoptosis and renal scarring. Kidney Int. 1996;49(suppl 54):S14-S17.
28. Alfrey AC, Fromment DH, Hammond WS: Role of iron in tubulointerstitial injury in nephrotoxic serum nephritis. Kidney Int 1989;36:753-759.
29. Howard RL, Buddington B, Alfrey AC: Urinary albumin, transferrin and iron excretion in diabetic patients. Kidney Int 1991;40:923-926.
30. Maack T, Park CH, Camargo MJF: Renal filtration, transport, and metabolism of proteins: in Seldin DW (ed): The Kidney: Physiology and Pathophysiology. New York; Raven Press, 1985; pp 1773-1803.
31. Olbricht CJ, Cannon JK, Tisher CC: Cathepsin B and L in nephron segments of rats with puromycin aminonucleoside nephrosis. Kidney Int 1987;32:354-361.
32. Woo D: Apoptosis and loss of renal tissue in polycystic kidney disease. N Engl J Med 1995; 333:18-2.5.
33. Hocher B, Rohmeiss P, Thone-Reineke C, et al: Apoptosis in kidneys of endothelin-1 transgenic mice. J Cardiovasc Pharmacol 1998;31: S554-556.
34. Oliver J: Architecture of the Kidney in Chronic Bright's Disease. New York; Hoeber, 1939.
35. Marcussen N: Atubular glomeruli in chronic renal disease. Curr Top Pathol 1995;88:145-174.
36. Marcussen N, Olsen TS: Atubular glomeruli in patients with chronic pyelonephritis. Lab. Invest. 1990;62:467-478.
37. Marcussen N: Atubular glomeruli in renal artery stenosis. Lab Invest 1991;65:558-572.
38. Marcussen N, Nyengaard JR, Christensen S: Compensatory growth of glomeruli is accompanied by an increased number of glomerular capillaries. Lab Invest 1994;70:868-874.
39. Maxwell PH, Osmond MK, Pugh CW, et al: Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993;44:1149-1162.
40. Maxwell PH, Ferguson DJP, Nicholls LG, Johnson MH, Ratcliffe PJ: The interstitial response to renal injury: Fibroblast-like cells show phenotypic changes and have reduced potential for erythropoietin gene expression. Kidney Int 1997;522:715-724.
41. Müller GA, Markovic-Lipkovski J, Frank J, Rodemann HP: The role of interstitial cells in the progression of renal diseases. J Am Soc Nephrol 1992;2:S198-S205.
42. D'Amico G, Ferrario F, Rastaldi MP: Tubulointerstitial damage in glomerular diseases: Its role in the progression of renal damage. Am J Kid Dis 1995;26:124-132.
43. Alexopoulos E, Seron D, Hartley RB, Nolasco F, Cameron JS: Immune mechanisms in idiopathic membranous nephropathy: the role of interstitial infiltrates. Am J Kidney Dis 1989; 13:404-412.
44. Alexopoulos E, Seron D, Hartley RB, Cameron JS: Lupus nephritis: correlation of interstitial cells with glomerular function. Kidney Int 1990;37:100-109.
45. Müller GA, Rodemann HP, Markovic-Lipkovski J, Müller CA, Mackensen-Haen S, Bohle A: Consequences of tubulointerstitial changes on renal function; in D'Amico G, Colasantini G (eds): Issues in Nephrosciences: Dialysis Strategies, Interstitial Infiltrates in Glomerulonephritis, Diabetic Nephropathy. Milano, Wichtig Editore, 1991; pp 1062-1181.
46. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-1456.
47. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG: The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 1978;10:213-218.
48. Klahr S, Levey AS, Beck GJ, et al: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group (see comments). N Engl J Med 1994;330:877-84.
49. Zoja C, Morigi M, Figliuzzi M, et al: Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 1995;26:934-941.
50. Hanggono T, Rao GS: Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers. Biochem. Biophys Res Comm 1992;189:994-1000.
51. Wang Y, Chen J, Chen L, Tay YC, Rangan GK, Harris DC: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997;8: 1537-1545.
52. Zoja C, Donadelli R, Colleoni S, et al: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Kidney Int 1998;53:1608-1615.
53. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G: In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998;9:1213-1224.
54. Oldberg A, Franzen A, Heinegard D: Cloning and sequence of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 1986;83:8819-8823.
55. Pichler R, Giachelli CM, Lombardi D, Alpers CE, Schwartz SM, Johnson RJ: Tubulointerstitial disease in glomerulonephritis: potential role of osteopontin (uropontin). Am J Pathol 1994;144:915-926.
56. Giachelli CM, Pichler R, Lombardi D, et al: Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int 1994;45:515-524.
57. Nath KA, Hostetter MK, Hostetter TH: Pathophysiology of chronic tubulointerstitial disease in rats: interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 1985;76:667-675.
58. Hocher B, Thone-Reineke C, Rohmeiss P, et al: Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 1997;99:1380-1389.
59. Costigan M, Chambers DA, Boot-Handford RP: Collagen turnover in renal disease. Exp Nephrol 1995;3:114-121.
60. Stetler-Stevenson WG, Liotta LA, Kleiner DE: Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993;7:1434-1441.
61. Tang WW, Feng L, Xia Y, Wilson CB: Extracellular matrix accumulation in immune-mediated tubulointerstitial injury. Kidney Int 1994; 45:1077-1084.
62. Eddy AE, Giachelli CM, McCulloch L, Liu E: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 1995; 47:1546-1557.
63. Jones CL, Fecondo J, Kelynack K, Forbes J, Walker R, Becker G: Tissue inhibitor of the metalloproteinases and renal extracellular matrix accumulation. Exp Nephrol 1995;3:80-86.
64. Duymelinck C, Deng JT, Dauwe SE, De Broe ME, Verpooten GA: Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy (in process citation). Kidney Int 1998;54:804-818.
65. Uria JA, Werb Z: Matrix metalloproteinases and their expression in mammary gland (in process citation). Cell Res 1998;8:187-194.
66. Eddy A, Soloway P: Renal interstitial fibrosis in mice with overload proteinuria: TIMP-1 deficiency is not protective (abstract). J Am Soc Nephrol. 1998;9:515A.
67. Vassalli J-D, Sappino A-P, Belin D: The plasminogen activator/plasmin system. J Clin Invest 1991;88:1067-1072.
68. Oikawa T, Freeman M, Lo W, Vaughan DE, Fogo A: Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int 1997;51:164-172.
69. Frank J, Engler-Blum G, Rodemann HP, Müller GA: Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and 11-6 mRNA expression in vitro. Exp Nephrol 1993; 1:26-35.
70. Johnson DW, Saunders HJ, Baxter RC, Field MJ, Pollock CA: Paracrine stimulation of human renal fibroblasts by proximal tubule cells (in process citation). Kidney Int 1998;54:747-757.
71. Lonnemann G, Shapiro L, Engler-Blum G, Müller GA, Koch KM, Dinarello CA: Cytokines in human renal interstitial fibrosis. I. IL-1 is an autocrine growth factor for cultured fibrosis-derived kidney fibroblasts. Kidney Int. 1995;47:837-844.
72. Strutz F, Zeisberg M, Dietrich M, et al: Basic fibroblast growth factor (FGF-2) expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation. Submitted. 1998.
73. Phillips AO, Topley N, Morrisey K, Williams JD, Steadman R: Basic fibroblast growth factor stimulates the release of preformed transforming growth factor β1 from human proximal tubular cells in the absence of de novo gene transcription or mRNA translation. Lab Invest 1997;76:591-600.
74. Wiggins R, Goyal M, Merritt S, Killen PD: Vascular adventitial cell expression of collagen I mesenger ribonucleic acid in anti-glomerular basement membrane antibody-induced crescentic nephritis in the rabbit. Lab Invest 1993; 68:557-565.
75. Ziyadeh F, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 1990;259:F704-F714.
76. Creely JJ, DiMari SJ, Howe AM, Haralson MA: Effects of transforming factor-β on collagen synthesis by normal rat kidney epithelial cells. Am J Pathol 1992;140:45-55.
77. Humes HD, Nakamura T, Cieslinski DA, Miller D, Emmons RV, Border WA: Role of proteoglycans and cytoskeleton in the effects of TGF-beta 1 on renal proximal tubule cells. Kidney Int 1993;43:575-584.
78. Humes HD, Beals TF, Cieslinski DA, Sanchez IO, Page TP: Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells. Lab Invest 1991;64:538-545.
79. Strutz F, Okada H, Lo CW, et al: Identification and characterization of fibroblast-specific protein 1 (FSP1). J Cell Biol 1995;130:393-405.
80. Okada H, Danoff TM, Fischer A, Lopez-Guisa JM, Strutz F, Neilson EG: Identification of a novel cis-acting element for fibroblast-specific transcription of the FSP1 gene. Am J Physiol 1998;275:F306-314.
81. Hay ED, Zuk A: Transformations between epithelium and mesenchyme: Normal, pathological, and experimentally induced. Am J Kidney Dis 1995;26:678-690.
82. Nadasdy T, Laszik Z, Blick KE, Johnson DL, Silva FG: Tubular atrophy in the end-stage kidney: A lectin and immunohistochemical study. Hum Pathol 1994;25:22-28.
83. Ng YY, Huang TP, Yang WC, et al: Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats (in process citation). Kidney Int 1998;54:864-876.
84. Dautheville S, Fischer E, Mougenot B, Delauche M, Ronco P, Rossert J: Identification of type I collagen-producing cells during interstitial fibrosis induces by unilateral ureteral obstruction (UUO) (abstract). J Am Soc Nephrol. 1998;9:514A.
85. Fine LG, Orphanides C, Norman JT: Progressive renal disease: The chronic hypoxia hypothesis. Kidney Int. 1998;53(Suppl 65):S74-S78.
86. Fine LG, Ong AC, Norman JT: Mechanisms of tubulo-interstitial injury in progressive renal diseases. Eur J Clin Invest 1993;23:259-265.
87. Fisher JW: Erythropoietin: Physiologic and pharmacologic aspects. Proc Soc Exp Biol Med 1997;216:358-369.
88. Ong AC, Jowett TP, Firth JD, Burton S, Karet FE, Fine LG: An endothelin-1 mediated autocrine growth loop involved in human renal tubular regeneration. Kidney Int 1995;48:390-401.
89. Orphanides C, Fine LG, Norman JT: Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. Kidney Int 1997;52:637-647.
90. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990; 85:541-549.
91. Müller GA, Schettler V, Müller CA, Strutz F: Renal Fibrosis: Prevention of progression -how far are we? Kidney Int 1996;49(suppl 54): S75-S82.